Health-tech company Pristyn Care is realigning its strategy, demerging its consumer brand BeatXP and scaling back its medical supply unit MedX. The startup aims to prioritize its core hospital network, with plans to grow its owned hospital count to 19-20 facilities over the next 18 months.
Pristyn Care is undertaking a major strategic shift, moving away from peripheral consumer businesses to concentrate on its core hospital network. The health-tech company is demerging its consumer-facing brand, BeatXP, and repositioning it toward the sports footwear and athleisure market. Simultaneously, it is scaling back its medical supply venture, MedX, to prioritize resource allocation toward its clinical infrastructure.
This strategic pivot comes as the company aims to move away from its previous consumer-focused ventures, which faced challenges in market traction. The BeatXP brand, which previously focused on health-tech wearables, will see a significant reduction in planned investment. The company intends to limit future funding for the brand to approximately $2 million over the next two years, a sharp decline from the $10-12 million previously allocated. This decision follows a period where the brand’s revenue saw a sharp decline.
At the center of this new strategy is the expansion of Pristyn Care’s hospital network. The company currently operates nine hospitals, which contribute roughly 35% of its total revenue, with the remainder coming from partner facilities. The management plans to increase the number of owned hospitals to 19-20 within the next 12 to 18 months. This expansion is designed to shift the revenue mix, with the company aiming for owned hospitals to contribute 50-60% of its total revenue in the future. Beyond elective surgeries, the company plans to broaden its service offerings to include diagnostics, intensive care, and neonatal care.
Financially, the company has been navigating a period of restructuring. In FY25, its consolidated revenue stood at ₹442 crore, compared to ₹600 crore in the previous year. However, the company has focused on narrowing its losses, which decreased to ₹168 crore from ₹381 crore in the previous year. To support its expansion, Pristyn Care is finalizing a ₹180 crore investment from GIFT City-based Spec Finance (IFSC) Pvt. Ltd.
The shift toward an owned hospital model marks a transition toward a more capital-intensive business structure. While this allows for greater control over service quality and patient experience, it requires significant upfront spending on land, building, and medical equipment. The primary risk for the company in this phase will be the execution of this expansion while maintaining operational efficiency. Investors and stakeholders will likely monitor whether the company can achieve the projected revenue mix and maintain its path toward sustained profitability without relying heavily on external funding.